ConductScience.org, home

Paper34813613

Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations.

Kulkarni T and 10 others. PLoS One, 2021. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations. Papers, record 34813613. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34813613

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations.
PubMed
Journal
PLoS One
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2024-11-23
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kulkarni TTejaswini
2Valentine VGVincent G
3Fei FFei
4Tran-Nguyen TKThi K
5Quesada-Arias LDLuisa D
6Mkorombindo TTakudzwahttps://orcid.org/0000-0001-7391-2711
7Pham HPHuy P
8Simmons SCSierra C
9Dsouza KGKevin G
10Luckhardt TTracy
11Duncan SRSteven Rhttps://orcid.org/0000-0001-8655-9072

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Idiopathic Pulmonary FibrosisMajor topic
Immunoglobulins, IntravenousMajor topic
Immunologic FactorsMajor topic
Plasma ExchangeMajor topic
RituximabMajor topic
Acute Disease
Aged
Autoantibodies
Female
Humans
Male
Prospective Studies

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 HL105346NHLBI NIH HHSUnited StatesT32HL105346PubMedNIH RePORTER
U01 HL133232NHLBI NIH HHSUnited StatesU01HL133232PubMedNIH RePORTER

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123171098Intravenous immune globulin in autoimmune and inflammatory diseases.N Engl J Med2012https://conductscience.org/library/papers/23171098PubMed
210871435Elevation of anti-cytokeratin 18 antibody and circulating cytokeratin 18: anti-cytokeratin 18 antibody immune complexes in sera of patients with idiopathic pulmonary fibrosis.Lung2000https://conductscience.org/library/papers/10871435PubMed
324107778BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.Sci Transl Med2013https://conductscience.org/library/papers/24107778PubMed
420077121Advances in diagnosing and managing antibody-mediated rejection.Pediatr Nephrol2010https://conductscience.org/library/papers/20077121PubMed
519204770Removal kinetics of therapeutic apheresis.Blood Transfus2007https://conductscience.org/library/papers/19204770PubMed
617585107Acute exacerbations of idiopathic pulmonary fibrosis.Am J Respir Crit Care Med2007https://conductscience.org/library/papers/17585107PubMed
724628285C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.Am J Respir Crit Care Med2014https://conductscience.org/library/papers/24628285PubMed
811694958Autoantibodies to IL-1 alpha in sera from rapidly progressive idiopathic pulmonary fibrosis.J Med Invest2001https://conductscience.org/library/papers/11694958PubMed
927159038Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.PLoS One2016https://conductscience.org/library/papers/27159038PubMed
1011467755Treatment of autoimmune disease: synergy between plasma exchange and intravenous immunoglobulins.Ther Apher2001https://conductscience.org/library/papers/11467755PubMed
1125441030B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.J Autoimmun2015https://conductscience.org/library/papers/25441030PubMed
1226160873An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.Eur Respir J2015https://conductscience.org/library/papers/26160873PubMed
1322282550Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy.Eur Respir J2012https://conductscience.org/library/papers/22282550PubMed
1421373184The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis.PLoS One2011https://conductscience.org/library/papers/21373184PubMed
1528356570Idiopathic pulmonary fibrosis and a role for autoimmunity.Immunol Cell Biol2017https://conductscience.org/library/papers/28356570PubMed
1628754682Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis.J Immunol2017https://conductscience.org/library/papers/28754682PubMed
1717108669Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.Respiration2007https://conductscience.org/library/papers/17108669PubMed
1820595144Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.Eur Respir J2011https://conductscience.org/library/papers/20595144PubMed
1912209492Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.Arthritis Rheum2002https://conductscience.org/library/papers/12209492PubMed
2027299520Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.Am J Respir Crit Care Med2016https://conductscience.org/library/papers/27299520PubMed

See all 42 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42447235Acute exacerbation in fibrotic interstitial lung disease: an international working group report.Am J Respir Crit Care Med2026https://conductscience.org/library/papers/42447235PubMed
41470099Acute Exacerbation of Interstitial Lung Disease: Early Diagnosis and Treatment.Medicina (Kaunas)2025https://conductscience.org/library/papers/41470099PubMed
40604645Machine learning-based integration identifies plasma cells-related gene signature ST6GAL1 in idiopathic pulmonary fibrosis.BMC Pulm Med2025https://conductscience.org/library/papers/40604645PubMed
40124525The Intersection between Immune System and Idiopathic Pulmonary Fibrosis-A Concise Review.Fibrosis (Hong Kong)2025https://conductscience.org/library/papers/40124525PubMed
39737178The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis.Front Immunol2024https://conductscience.org/library/papers/39737178PubMed
39403408Understanding myofibroblast origin in the fibrotic lung.Chin Med J Pulm Crit Care Med2024https://conductscience.org/library/papers/39403408PubMed
39144320Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments.J Thorac Dis2024https://conductscience.org/library/papers/39144320PubMed
38869027Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectivesMultidiscip Respir Med2024https://conductscience.org/library/papers/38869027PubMed
38509495Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.BMC Pulm Med2024https://conductscience.org/library/papers/38509495PubMed
38465342Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features.Open Life Sci2024https://conductscience.org/library/papers/38465342PubMed
37673443Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease.RMD Open2023https://conductscience.org/library/papers/37673443PubMed
36004373Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break.Front Med (Lausanne)2022https://conductscience.org/library/papers/36004373PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CXCL1310563PubTator's text mininghttps://conductscience.org/library/genes/10563NCBI Gene
F82157PubTator's text mininghttps://conductscience.org/library/genes/2157NCBI Gene
FGB2244PubTator's text mininghttps://conductscience.org/library/genes/2244NCBI Gene
HSPA43308PubTator's text mininghttps://conductscience.org/library/genes/3308NCBI Gene
NEUROG14762PubTator's text mininghttps://conductscience.org/library/genes/4762NCBI Gene
TNFSF138741PubTator's text mininghttps://conductscience.org/library/genes/8741NCBI Gene
TNFSF13B10673PubTator's text mininghttps://conductscience.org/library/genes/10673NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34813613

GET https://conductscience.org/api/papers/v1/34813613/references?page=2